In addition, in vitro treatment of colonic epithelial cells with AmEVs reduced the production of IL-6, and oral administration of AmEV to mice alleviated DSS-induced colitis phenotypes such as inflammatory cell infiltration, weight loss, and shortened colonic length[14]. The gene discussed is IL6; the disease is colitis.